Login Register Cart 0

Articles by Disease (Brain Diseases)

A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 29
Page: 4138-4151
Author(s): Stefania Merighi*, Pier A. Borea, Katia Varani, Fabrizio Vincenzi, Kenneth A. Jacobson* and Stefania Gessi*

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 29
Page: 4293-4300
Author(s): Sebastian M. Klein, Maria Bozko, Astrid Toennießen, Nisar P. Malek and Przemyslaw Bozko*

A State-of-the-art Review and Prospective Therapeutic Applications of Prenyl Flavonoids as Chemosensitizers against Antifungal Multidrug Resistance in Candida albicans

Journal: Current Medicinal Chemistry
Volume: 29
Page: 4251-4281
Author(s): María Daniela Santi, María Gabriela Ortega and Mariana Andrea Peralta*

Abrogating Oxidative Stress as a Therapeutic Strategy Against Parkinson’s Disease: A Mini Review of the Recent Advances on Natural Therapeutic Antioxidant and Neuroprotective Agents

Journal: Medicinal Chemistry
Volume: 18
Page: 772-783
Author(s): Thekla Theofanous* and Malamati Kourti*

Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets

Journal: Current Molecular Pharmacology
Volume: 15
Page: 736-762
Author(s): Aliabbas Zia, Tahereh Farkhondeh, Faezeh Sahebdel, Ali Mohammad Pourbagher-Shahri and Saeed Samarghandian*

Development and Validation of a Sensitive UPLC-Q-TOF-MS/MS for the Measurement of Nine Components in Rat Plasma and Tissues and its Application to Pharmacokinetics and Tissue Distribution Studies with Xuanfei Baidu Granules

Journal: Current Drug Metabolism
Volume: 23
Page: 150-163
Author(s): Xinrui Wang, Shuai Quan, Han Zhang, Xinbo Song, Jingze Zhang* and Dailin Liu*

Caveolin-1: A Promising Therapeutic Target for Diverse Diseases

Journal: Current Molecular Pharmacology
Volume: 15
Page: 701-715
Author(s): Shivani Gokani and Lokesh Kumar Bhatt*

Recent Update on the Development of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors: A Promising Target for the Treatment of Parkinson’s Disease

Journal: Medicinal Chemistry
Volume: 18
Page: 757-771
Author(s): Ashish Patel*, Stuti Patel, Meshwa Mehta, Yug Patel, Dhruv Langaliya, Shyam Bhalodiya and Tushar Bambharoliya

A Proteomics Study of the Subacute Toxicity of Rat Brain after Long- Term Exposure of Gelsemium elegans

Journal: Current Molecular Pharmacology
Volume: 15
Page: 794-801
Author(s): Meng-Ting Zuo, Si-Juan Huang, Yong Wu, Mo-Huan Tang, Hui Yu, Xue-Jia Qi and Zhao-Ying Liu*

Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Journal: Current Pharmaceutical Design
Volume: 28
Page: 806-828
Author(s): Shweta Goyal, Brashket Seth and Rajnish K. Chaturvedi*